Cure My Disease

Don't miss your cure!

 Log in / Sign up

A wearable sensor may soon read your body's response to food

NCT ID NCT06582381

Knowledge-focused Sponsor: Texas A&M University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

Researchers at Texas A&M University are studying whether small molecules in blood and skin fluid can predict how the body handles carbohydrates, protein, and fat from meals. The study involves 30 adults aged 50 to 75 who will eat different test meals and have their blood and skin fluid sampled. The goal is to build prediction models that could one day power wearable devices to track nutrient processing in real time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Specially designed meals with different combinations of carbohydrates, protein, and fat
What this could lead to
If successful, this could lead to wearable sensors that tell people in real time how their body is processing the foods they eat, helping with personalized nutrition.
What could go wrong
This is a small, early-stage study with only 30 participants, so the results may not apply to everyone. The prediction models may not be accurate enough for real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Dec 2023

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Ability to walk, sit down and stand up independently * Age 50-75 years old * Ability to lie in supine or slightly elevated position for approximately 13 hours * BMI between 25 and 35 * Willingness and ability to comply with the protocol Exclusion Criteria * Established diagnosis of malignancy * Established diagnosis of Insulin or non-Insulin Dependent Diabetes Mellitus * History of untreated metabolic diseases including hepatic or renal disorder * Currently on anticoagulants (i.e., warfarin, factor X inhibitors or direct thrombin inhibitors) * History of deep vein thrombosis, pulmonary embolisms, or known clotting disorders * Presence of acute illness or metabolically unstable chronic illness * Recent myocardial infarction (less than 1 year) * Known allergy or intolerance to any of the meal components * Any other condition according to the PI or nurse that was found during the screening visit, that would interfere with the study or safety of the patient * Failure to give informed consent or Investigator\'s uncertainty about the willingness or ability of the participant to comply with the protocol requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amino acid metabolism are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amino acid metabolism disease glucose metabolism disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Amino acid metabolism Glucose metabolism

Contacts and locations

Locations

  • Center for Translational Research in Aging & Longevity

    College Station, Texas, 77843, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.